[Antibacterial therapy of liver abscesses].
An experience with the treatment of 298 patients with parasitogenic (240) and bacterial (58) abscesses is described. Lethality among the first group was 5,4%, among the second group 32,7%.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004444:Echinococcosis, Hepatic / Q000188:drug therapy; D004640:Emetine / Q000627:therapeutic use; D004980:Ethane / Q000031:analogs & derivatives*; D006801:Humans; D006843:Hydrocarbons, Chlorinated / Q000627:therapeutic use; D008100:Liver Abscess / Q000188:drug therapy*; D008101:Liver Abscess, Amebic / Q000188:drug therapy; D008109:Liver Diseases, Parasitic / Q000188:drug therapy*; D009889:Opisthorchiasis / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D006843:Hydrocarbons, Chlorinated; C010182:hexachloroethane; D004980:Ethane; D004640:Emetine
Antibakterial'naia terapiia abstsessov pecheni.